FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, particularly to a method for producing a nootropic composition based on polypeptide complexes isolated from neuronal progenitor cells under heat shock. Said composition is characterised by the fact that it contains proteins and polypeptides with a molecular weight from 3 kDa to 250 kDa, 60% whereof have a molecular weight in the range from 10 to 50 kDa, brain-derived neurotrophic factor (BDNF) no less than 120 pg/ml, and glial cell line-derived neurotrophic factor (GDNF) no less than 40 pg/ml, vascular endothelial growth factor (VEGF) not less than 60 pg/ml, total protein weight no less than 1 mg/ml of the preparation. The cell culture of neuronal progenitor cells therein, wherefrom the composition is produced, demonstrates the expression of a β3-tubulin neuronal marker, a nerve cell adhesion molecule (PSA-NCAM), and consists of 99.5±2.45% TUBB3+ cells.
EFFECT: invention allows effectively producing a protein-peptide composition including not only small peptides, but also full-size protein neuronal growth and differentiation factors the effectiveness whereof is invariably higher than in short peptides and immunogenicity is not present.
2 cl, 2 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
NOOTROPIC COMPOSITION BASED ON POLYPEPTIDE COMPLEXES ISOLATED FROM GLIAL PROGENITOR CELLS UNDER CONDITIONS OF HEAT SHOCK, AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2732599C1 |
NOOTROPIC COMPOSITION BASED ON POLYPEPTIDE COMPLEXES RECOVERED FROM NEURONAL PROGENITOR CELLS UNDER HYPOXIC CONDITIONS, AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2732600C1 |
IMPROVED METHOD FOR DIFFERENTIATION OF INDUCED PLURIPOTENT HUMAN STEM CELLS INTO DOPAMINERGIC NEURONS | 2023 |
|
RU2823290C1 |
IMPROVED METHOD FOR OBTAINING BRAIN ORGANOIDS | 2022 |
|
RU2784072C1 |
METHOD OF PRODUCING CARTILAGE-LIKE STRUCTURES FROM STEM CELLS WITH INDUCED PLURIPOTENCY AND STRUCTURES OBTAINED USING SAID METHOD | 2023 |
|
RU2814248C1 |
CONVERSION OF SOMATIC CELLS INTO INDUCED REPROGRAMMED NEURAL STEM CELLS (IRNSC) | 2011 |
|
RU2562111C2 |
METHOD OF OBTAINING OF PATIENT (DONOR) - SPECIFIC FIBROBLAST-LIKE CELLS FROM INDUCED PLURIPOTENT HUMAN STEM CELLS | 2014 |
|
RU2568059C1 |
EVALUATION METHOD OF MORPHOFUNCTIONAL STATE OF INDUCED PLURIPOTENT STEM CELLS OF PARKINSONIAN PATIENTS, WHICH ARE DIFFERENTIATED TO DOPAMINERGIC NEURONS | 2012 |
|
RU2501853C1 |
METHOD OF SUBRETINAL TRANSPLANTATION OF RETINAL PIGMENT EPITHELIUM (RPE) CELLS DIFFERENTIATED FROM HUMAN INDUCED PLURIPOTENT STEM CELLS, WITH ATROPHY OF RETINAL PIGMENT EPITHELIUM IN EXPERIMENT | 2019 |
|
RU2729937C1 |
RECOMBINANT PLASMID pAd-SM, CODING HUMAN PROTEINS SOX2 AND C-MYC, BEING BASE FOR PRODUCTION OF VIRULENT ADENOVIRUSES DESIGNED FOR PRODUCTION OF INDUCED PLURIPOTENT HUMAN CELLS | 2012 |
|
RU2495127C2 |
Authors
Dates
2021-08-11—Published
2019-12-26—Filed